I nvariant NK T (iNKT)
4 cells represent an innate-like lymphocyte lineage that recognizes glycolipid Ags presented by CD1d, a nonclassical MHC class I-like molecule (1) . Largely defined within an immunoregulatory context, iNKT cells rapidly secrete both Th1 and Th2 cytokines within hours of stimulation (1) and are reported to be involved in the regulation of various pathologies, including autoimmunity, infectious disease, cancer, and allergy. In mice, iNKT cells develop intrathymically and are positively selected by CD1d-expressing CD4 ϩ
CD8
ϩ double-positive thymocyte precursors (2) . The positive selection of iNKT cells by a double-positive thymocyte is believed to induce a developmental pathway distinct from that observed for naive "conventional" MHC-restricted T cells and has been substantiated by a number of in vivo models (1) . In this context, at least four distinct iNKT cell populations have been identified in the murine thymus based on surface expression of heat-stable Ag, CD44, and NK1.1 (2) . The subsequent functional maturation of iNKT cells is associated with the gradual skewing towards a Th1 cytokine profile and the upregulation of CD44 and NK1.1 (2) . Accordingly, this maturation profile is accompanied by a migratory and/or homeostatic transitional stage where iNKT thymocytes seed the peripheral compartment as an immature CD44 high NK1.1 Ϫ subset (2), while ϳ75% of iNKT remain in the organ as a mature cell expressing NK1.1 (3). To date, no steady-state murine model offers an explanation for this finding, as it cannot be reconciled with the synchronous or "conveyor belt" model used to define conventional T cell export (4). The latter model proposes that conventional T cells exit the thymus as fully mature lymphocytes expressing a chemokine receptor profile associated with naive T cells (4) . The finding that mature iNKT cells are retained in the thymus therefore contradicts the current model used to define mature T cell export, as it would be expected that final iNKT cell maturation be accompanied by export to the periphery. In this context, published data has suggested that the developmental maturation of iNKT thymocytes is associated with the up-regulation of inflammatory chemokine receptors such as CXCR3 (5) , and CXCR3 forms part of a set of genes shown to be repressed in naive CD4 ϩ thymocytes (6) . In this report, we propose that the up-regulation of CXCR3 in iNKT thymocytes promotes retention of the mature NK1.1 ϩ subset in the thymic medulla.
Materials and Methods

Reagents and antibodies
Rabbit polyclonal antisera specific for mouse CXCR3 have been previously described (7). The mAbs used in this study are CD44 (IM-7), TCR␤ (H57-597), CD4 (L3T4), CD8 (Ly-2), NK1.1 (PK136), CXCR3 (220803), Ly51 (6C3), gp38 (8.1.1), CXCL10 (AKE05), and normal goat IgG (XS08).
Mice
CXCR3
ϩ/ϩ (C57BL/6) and RAG Ϫ/Ϫ mice were from The Jackson Laboratory. CXCR3 Ϫ/Ϫ mice have been previously described (8) .
Thymectomized C57BL/6 mice were from Harlan. All mice were housed and bred according to the guidelines of the Ghent University (Ghent, Belgium) vivarium.
Cell preparation
Liver mononuclear cells were isolated using an adjusted 33% Percoll gradient. Cell suspensions from thymus and bone marrow were prepared by conventional methods. Peripheral blood was isolated by cardiac puncture and mononuclear cells were isolated using a Ficoll Paque Plus gradient (Pharmacia).
Flow cytometry
Cell surface stainings and tetramer stainings were performed as described previously (2). Cells were acquired on a FC500 (Beckman Coulter) or FACSCanto (Becton Dickinson) flow cytometer and analyzed using either CellQuest or FlowJo (Tree Star) software.
Chemotaxis assays
Murine chemokines were used at 250 nM CXCL9, 100 nM CXCL10, and 200 nM CXCL11 in 5-m pore, polycarbonate, 24-well tissue culture inserts (Costar). Thymocytes were harvested from the upper and lower wells after 90 min and stained for flow cytometry. For Fig. 1b , polystyrene beads (Polysciences) were used as an internal standard for absolute counts. The ratio of chemokine-driven vs spontaneous migration (migration index) was calculated as follows: (absolute no. of iNKT cells/absolute no. of beads) chemokine well / (absolute no. of iNKT cells/absolute no. of beads) blank medium well . For Fig. 1d , the absolute no. of iNKT cell subsets were normalized against the absolute no. of Tet Ϫ CD4 ϩ ␤TCR high T cells.
Immunofluorescence
Eight-micrometer cryosections from 5-wk-old thymi were stained with 6C3 and 8.1.1 and visualized using Alexa Fluor 647-or Alexa Fluor 488-conjugated anti-rat IgG or anti-hamster IgG, respectively. Biotinylated anti-CXCL10 or anti-goat IgG were amplified with a TSA (tyramide signal amplification) kit (Invitrogen) and visualized with streptavidin-Alexa Fluor 546. Sections were analyzed on a Leica TCS SP2 confocal laser scanning microscope (Leica Microsystems).
Bone marrow transfers
T cell-depleted bone marrow cells ( 10 7 ) were i.v. transferred into sublethally gamma-irradiated 8-wk-old RAG Ϫ/Ϫ recipient mice. Thymus, liver, and spleen of recipients were analyzed 10 wk after bone marrow-transfer.
Intrathymic injections and in vivo administration of antagonistic anti-CXCR3 sera
Each thymic lobe was injected with 10 l of FITC (Molecular Probes) dissolved in PBS (1 mg/ml) and iNKT recent thymic emigrants (RTEs) were analyzed at 40 h postinjection. The migration index was calculated as follows: (absolute number of FITC ϩ iNKT cells/conventional T cells) periphery /(absolute number of FITC ϩ iNKT cells/conventional T cells) thymus . For blocking experiments, 5-to 6-wk old euthymic mice were injected i.p. and intrathymically with anti-CXCR3 or control serum (500 l i.p. and 10 l/lobe) before an intrathymic injection with FITC. Mice were sacrificed 40 h later. Thymectomized mice were injected i.p. with 500 l of anti-CXCR3 or control sera and were sacrificed 40 h later.
Statistical analysis
The statistical test used throughout this study was Student's t test (unpaired, two-sided). 
Results and Discussion
CXCR3 is developmentally regulated in iNKT thymocytes and induces chemotaxis in the mature NK1.1 ϩ subset
Primary experiments revealed that ϳ70% of iNKT thymocytes expressed the chemokine receptor CXCR3 (Fig. 1a) and induced a functional response toward CXCL9, CXCL10, and CXCL11 in in vitro Transwell migration assays (Fig. 1b) . However, CXCR3 surface expression could not be detected on conventional CD4 ϩ or CD8 ϩ ␤TCR high thymocytes, and no significant CXCR3-dependent response was observed for these subsets in the presence of CXCL9, CXCL10, or CXCL11 (Fig.  1, a and b; data not shown) . A subsequent phenotypic analysis of iNKT thymocyte subsets revealed that CXCR3 up-regulation correlated well with their maturation profiles, as the highest level of expression was detected on mature NK1.1 ϩ cells (Fig. 1c) . In this study, a functional response was observed for mature CD44 high NK1.1 ϩ iNKT thymocytes in the presence of CXCL10 (Fig. 1d ) and CXCL11 (data not shown) and was CXCR3 dependent, as no chemotaxis was observed in CXCR3 Ϫ/Ϫ iNKT thymocytes (data not shown). Immunohistochemical analysis of thymic stroma revealed that isolated 8.1.1 ϩ medullary thymic epithelial cells constitutively expressed CXCL10 in an area adjacent to the corticomedullary junction (Fig. 1, e-g ). The constitutive expression of CXCR3 ligands in C57BL/6 thymi appears to be restricted to CXCL10 (9) , as C57BL/6 mice have been shown to lack a functional copy of CXCL11 (10) and we were unable to detect CXCL9 immunohistochemically using several commercially available Abs (data not shown). This would suggest that the expression of CXCR3 ligands in murine and human thymic stroma is differentially regulated (9, 11) .
Hematopoietic expression of CXCR3 regulates thymic homeostasis of mature iNKT cells
Analysis of T cell subsets in the thymus of CXCR3
Ϫ/Ϫ mice revealed a significant reduction in the percentage of iNKT thymocytes when compared with CXCR3 ϩ/ϩ controls (Fig. 2a) . This reduction was most pronounced in the mature NK1.1 ϩ subset (Fig. 2, b and c) , whereas no significant difference was observed for positively selected CD4 ϩ or CD8 ϩ ␤TCR high conventional T cell subsets (data not shown). Furthermore, 
RAG-1-deficient mice reconstituted with CXCR3
Ϫ/Ϫ bone marrow reproduced the mature iNKT cell phenotype observed in CXCR3 Ϫ/Ϫ thymi (Fig. 2d) , demonstrating that the hematopoietic expression of CXCR3 serves to regulate mature iNKT cell homeostasis in the thymus.
Germline CXCR3 deficiency results in iNKT lymphocytosis
A subsequent analysis of iNKT cell frequencies in several peripheral organs showed a consistently higher percentage and absolute number of iNKT cells in the peripheral blood (PB) of CXCR3 Ϫ/Ϫ animals (Fig. 3, a and c) . Subset analysis of PB iNKTs suggested an enrichment in the percentage of CD4 ϩ NK1.1 Ϫ and double-negative NK1.1 ϩ iNKT subsets (Fig. 3b) ; however, lymphocytosis was observed in all major iNKT cell subsets (supplemental. Fig. 1, b-e ) 5 and almost all circulating iNKT subsets expressed CXCR3 (supplemental Fig. 1a) . No significant differences were observed in iNKT cell percentages or absolute numbers in organs such as the liver (Fig. 3, e-g; supplemental Fig. 1, f-j) , spleen, lymph nodes, or bone-marrow (data not shown), and the deficiency did not skew the distribution of conventional T cells present in the blood and hepatic compartments (Fig. 3, d and h ). These findings therefore suggest a role for CXCR3 in maintaining a steady-state distribution of iNKT cells between the thymus and peripheral circulation in mice.
CXCR3-deficiency augments thymic iNKT cell emigration
The role of CXCR3 in maintaining a steady-state distribution of iNKT cells in the thymus was assessed by injecting CXCR3 ϩ/ϩ and CXCR3 Ϫ/Ϫ mice intrathymically with FITC (2, 3, 12) . These experiments revealed a reduction in both the percentage and number of FITC ϩ iNKT thymocytes in CXCR3 Ϫ/Ϫ thymi (Fig. 4, a and b ), yet an overall increase in the percentage and absolute number of circulating FITC ϩ iNKT RTEs (Fig. 4, b and d) . This result appeared to be specific for iNKT RTEs, as no significant difference was observed in the numbers of circulating FITC ϩ conventional T cell RTEs (Fig.  4, e and f) . When expressed as an overall migration index, iNKT RTEs emigrated from CXCR3 Ϫ/Ϫ thymi at a higher rate than that observed for CXCR3 ϩ/ϩ thymi (Fig. 4, g and h) and could be pharmacologically induced in CXCR3 ϩ/ϩ mice. In this study, peripheral and intrathymic CXCR3 antagonism before FITC injections (see Materials and Methods) resulted in an increased percentage of circulating FITC ϩ iNKT RTEs (Fig. 4i ) and an elevated iNKT cell export rate (Fig. 4, j and k) . Furthermore, CXCR3 antagonism in thymectomized C57BL/6 mice failed to modulate peripheral iNKT cell frequencies (data not shown), which argues against a role for CXCR3 in regulating peripheral iNKT cell homeostasis. We therefore propose that the iNKT lymphocytosis observed in CXCR3 Ϫ/Ϫ mice is the cumulative result of an inability to retain mature iNKT cells in the steady-state thymus and that the reduction in numbers of mature iNKT thymocytes in CXCR3 Ϫ/Ϫ mice reflects this retention defect.
In conclusion, the targeting of CXCR3 in mice is associated with a significantly decreased intrathymic accumulation of mature NK1.1 ϩ iNKT thymocytes. These findings provide the basis for a model in which CXCR3 promotes the migration and retention of mature iNKT cells within the thymic medulla, presumably in response to CXCR3 ligands such as CXCL10. These findings would appear to be analogous to inflammatory models in which CXCR3 is defined as a homing receptor for activated effector T cells (13) , NK cells (14) , and dendritic cells (15) . The subsequent production of IFN-␥ by recruited CXCR3 ϩ cells is postulated to amplify and extend the production of chemokines such as CXCL9, CXCL10, and CXCL11 in compartments such as the endothelium. In the context of iNKT cell biology, it remains to be determined whether Th1 cytokine production by mature iNKT cells regulates CXCR3 ligand expression within the thymic epithelium, as neither immature nor mature iNKT cells produce detectable cytokine protein before cognate stimulation (16) .
